Endoluxe Valuation Estimate
Endoluxe Valuation as of Last Funding Round
Endoluxe Company Overview
Endoluxe is a company that specializes in wireless all-in-one endoscopy solutions. Their platform is designed to be the future of endoscopy, offering a wireless experience that is supported by a team with extensive medtech and healthcare finance experience. Endoluxe's technology is designed to help medical professionals get up and running quickly, with a focus on quality and operations. The company's leadership has held roles at various healthcare organizations, including Advanced Urology, NYU Langone Health, and KARL STORZ Endoscopy
Endoluxe Valuation History
Endoluxe Stock Price
The stock price of Endoluxe can be calculated by taking the valuation of the company divided by the number of shares outstanding. Because a private company can issue new shares at any time, we do not know the current number of shares outstanding.
For illustrative purposes, however, assuming Endoluxe has issued 250 million shares, at the estimated UpMarket valuation of $8.09 million, each share of Endoluxe stock would be worth $0.03.
Buy Endoluxe Stock
If you would like to buy shares in Endoluxe, please provide your information in the form at the top of this page and click the button titled “I want to buy this stock.”
One of our investor relations team members will contact you to discuss Endoluxe stock availability. Note: inquiries are non-binding and shares may only be purchased by accredited investors that meet all eligibility criteria.
UpMarket has offered many similar companies as Pre-IPO investments, including Airbnb, SpaceX, ByteDance, Plaid, Kraken, Databricks, and others. UpMarket also often has funds available that invest in a portfolio of companies potentially including, Endoluxe as well.
Endoluxe Management
Name | Position |
---|---|
Neal Patel | CEO |
Scott Dentino | COO |